PAREXEL to Present Leading Insights Regarding Key Industry Topics at 20th Annual Drug Information Association E...( BOSTON Feb. 25 /- Experts from PA...)

BOSTON, Feb. 25 /PRNewswire-FirstCall/ -- Experts from PAREXEL International Corporation (Nasdaq: PRXL), a leading global bio/pharmaceutical services provider, will present on key topics at the Drug Information Association's (DIA) 20th Annual EuroMeeting in Barcelona, Spain being held March 3 - 5, 2008. Attendees will benefit from presentations by some of PAREXEL's thought leaders, selected by the DIA to address industry issues including pharmacovigilance, globalization of clinical trials, data-driven patient recruitment, non-interventional studies, gene therapy regulations, combination products, biosimilars, and cosmeceuticals.

PAREXEL experts will present or chair the following sessions:

Monday, March 3

-- Pharmacovigilance and Medical Writing View With Emphasis on Practical

Solutions to the Pitfalls and Grey Areas (tutorial) - Alison Rapley,

Director, Medical Writing Services, Europe, Clinical Research Services

(9:00)

-- Navigating the Gene Therapy Regulations for Clinical Trials -- Cecil

Nick, Principal Consultant, PAREXEL Consulting

(11:00)

Tuesday, March 4

-- Globalization of Clinical Trials: Opportunities and Risks -- Session

Chair: Alberto Grignolo, Ph.D., Corporate Vice President and General

Manager, PAREXEL Consulting

(9:00)

-- Combination Products: Drug or Device? -- Cecil Nick, Principal

Consultant, PAREXEL Consulting

(9:00)

-- Data Driven Patient Recruitment: Tools for Early Planning and

Predictive Management (poster presentation) -- Petra Moll, Associate

Director, Clinical Operations, Clinical Research Services

Wednesday, March 5

-- Meeting Patient En
'/>"/>